Rhythm Pharmaceuticals Inc
RYTM
ISIN null / Valor 25337263
Rhythm Pharmaceuticals Inc
UMushroom community rating:
About company
Rhythm Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare genetic disorders of obesity, specifically those related to the melanocortin-4 receptor (MC4R) pathway. These disorders are distinct from general obesity and are characterized by early-onset, severe obesity and hyperphagia, a condition marked by an insatiable hunger. The company's primary focus is on addressing these rare MC4R pathway impairments to provide targeted therapeutic solutions for patients suffering from these debilitating conditions.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
7074 M
Market cap (USD)
466,907
Daily traded volume (Shares)
56.78 / 55.07
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Adrian Pusz
EQUITIES OF THE SAME SECTOR
